Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Outcomes of patients with heart failure with preserved ejection fraction discharged on treatment with neurohormonal antagonists after an episode of decompensation

  • Tost, Josep|||0000-0003-3846-9616
  • Llorens Soriano, Pere|||0000-0002-9291-7179
  • Cotter, Gad|||0000-0002-9613-3339
  • Davison, Beth A.
  • Jacob, Javier|||0000-0003-1101-1066
  • Gil, Víctor
  • Herrero-Puente, Pablo|||0000-0002-5529-5008
  • Martín-Sánchez, Francisco Javier|||0000-0002-5970-725X
  • Donea, Ruxandra
  • Rodríguez, Beatriz|||0000-0002-0402-3838
  • Lucas-Imbernon, Francisco Javier
  • Andueza, Juan Antonio
  • Mecina, Ana Belén
  • Torres Gárate, Raquel|||0000-0002-8731-9350
  • Piñera, Pascual|||0000-0001-9213-9357
  • Alquézar-Arbé, A.|||0000-0003-4164-274X
  • Espinosa, Bego|||0000-0001-9531-6451
  • Mebazaa, A.
  • Chioncel, O.|||0000-0002-3197-3628
  • Miró, Oscar|||0000-0002-7924-9751
Aims: To analyze the frequency with which patients with heart failure with preserved ejection fraction (HFpEF) discharged after an acute heart failure (AHF) episode are treated with antineurohormonal drugs (ANHD), the variables related to ANHD prescription and their relationship with outcomes. Methods: We included consecutive HFpEF patients (left ventricular ejection fraction ≥50%) discharged after an AHF episode from 45 Spanish hospitals whose chronic medications and treatment at discharge were available. Patients were classified according to whether they were discharged with or without ANHD, including beta-blockers (BB), renin-angiotensin-aldosterone-system inhibitors (RAASi) and mineralcorticosteroid-receptor antagonists (MRA). Co-primary outcomes consisted of 1-year all-cause mortality and 90-day combined adverse event (revisit to emergency department -ED-, hospitalization due to AHF or all-cause death). Secondary outcomes were 90-day adverse events taken individually. Adjusted associations of ANHD treatment with outcomes were calculated. Results: We analyzed 3,305 patients with HFpEF (median age: 83, 60% women), 2,312 (70%) discharged with ANHD. The ANHD most frequently prescribed was BB (45.8%). The 1-year mortality was 26.9% (adjusted HR for ANHD patients:1.17, 95%CI=0.98-1.38) and the 90-day combined adverse event was 54.4% (HR=1.14, 95%CI=0.99-1.31). ED revisit was significantly increased by ANHD (HR=1.15, 95%CI=1.01-1.32). MRA and BB were associated with worse results in some co-primary or secondary endpoints, while RAASi (alone) reduced 90-day hospitalization (HR=0.73, 98%CI=0.56-0.96). Conclusion: 70% of HFpEF patients are discharged with ANHD after an AHF episode. ANHD do not seem to reduce mortality or adverse events in HFpEF patients, only RAASi could provide some benefits, reducing the risk of hospitalization for AHF.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Early intravenous nitroglycerin use in prehospital setting and in the emergency department to treat patients with acute heart failure, Insights from the EAHFE Spanish registry

  • Miró, Oscar|||0000-0002-7924-9751
  • Llorens Soriano, Pere|||0000-0002-9291-7179
  • Freund, Yonathan
  • Davison, Beth A.
  • Takagi, Koji
  • Herrero-Puente, Pablo|||0000-0002-5529-5008
  • Jacob, Javier|||0000-0003-1101-1066
  • Martín-Sánchez, Francisco Javier|||0000-0002-5970-725X
  • Gil, Víctor
  • Rossello, Xavier|||0000-0001-6783-8463
  • Alquézar-Arbé, A.|||0000-0003-4164-274X
  • Jiménez-Fábrega, Francesc X.
  • Masip, Josep|||0000-0002-8612-9889
  • Mebazaa, Alexandre|||0000-0001-8715-7753
  • Cotter, Gad|||0000-0002-9613-3339
Background and objective: Although recommended for the treatment of acute heart failure (AHF), the use of intravenous (IV) nitroglycerin (NTG) is supported by scarce and contradicting evidence. In the current analysis, we have assessed the impact of IV NTG administration by EMS or in emergency department (ED) on outcomes of AHF patients. Methods: We analyze AHF patients included by 45 hospitals that were delivered to ED by EMS. Patients were grouped according to whether treatment with IV NTG was started by EMS before ED admission (preED-NTG), during the ED stay (ED-NTG) or were untreated with IV NTG (no-NTG, control group). In-hospital, 30-day and 365-day all-cause mortality, prolonged hospitalization (.